| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,300 | 2,800 | 16:39 |
| Zeit | Aktuelle Nachrichten
Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.10. | ABL Diagnostics: ABL Texcell Diagnostics Announces Termination of Vela Diagnostics Letter of Intent | 3 | Euronext | ||
| 20.10. | ABL Texcell Diagnostics Announces Termination of Vela Diagnostics Letter of Intent | 317 | Business Wire | The proposed acquisition in Singapore and the United States will not proceed
Regulatory News:
ABL Texcell Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) ("Company") an international life... ► Artikel lesen | |
| 19.10. | ABL Diagnostics: ABL Texcell Diagnostics Strengthens the Foundations of a Stable Shareholder Base and Pursues Its Growth Strategy | 1 | Euronext | ||
| 19.10. | ABL Texcell Diagnostics SA: ABL Texcell Diagnostics Strengthens the Foundations of a Stable Shareholder Base and Pursues Its Growth Strategy | 378 | Business Wire | Its principal shareholder, ABL Luxembourg, intends to prioritize long-term investors in connection with any potential future disposals of significant blocks of shares
Regulatory News:
ABL Texcell... ► Artikel lesen | |
| 16.10. | ABL Diagnostics: ABL Texcell Diagnostics: Notice of Appeal by the Public Prosecutor Regarding the IntegraGen Transfer Judgment | 4 | Euronext | ||
| ABL DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 16.10. | ABL Texcell Diagnostics SA: ABL Texcell Diagnostics: Notice of Appeal by the Public Prosecutor Regarding the IntegraGen Transfer Judgment | 410 | Business Wire | Regulatory News:
ABL Texcell Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6)("Company") informs its shareholders and all stakeholders that it has been notified of the notice of appeal filed... ► Artikel lesen | |
| 12.10. | ABL Diagnostics: ABL Texcell Diagnostics Strengthens Its Presence at Genopole and Opens a New Chapter in Precision Oncology With the Acquisition of IntegraGen's Assets and Operations | 1 | Euronext | ||
| 12.10. | ABL Texcell Diagnostics Strengthens Its Presence at Genopole and Opens a New Chapter in Precision Oncology With the Acquisition of IntegraGen's Assets and Operations | 708 | Business Wire | A few months after integrating Texcell's activities, ABL Texcell Diagnostics strengthens its expertise in precision oncology, human genetics and rare diseases, while continuing to build a leading... ► Artikel lesen | |
| 08.10. | ABL Diagnostics: ABL Texcell Diagnostics Announces Availability of All Invest Securities Research Flash Note #8 | 2 | Euronext | ||
| 08.10. | ABL Texcell Diagnostics Announces Availability of All Invest Securities Research Flash Note #8 | 502 | Business Wire | Revised report includes the contribution from TEXCELL activities
Regulatory News:
ABL Texcell Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) (the "Company"), a company specializing in... ► Artikel lesen | |
| 01.10. | ABL Diagnostics: ABL Texcell Diagnostics Raises Its 2026 Revenue Guidance to €13.5 Million - €14.0 Million | 4 | Euronext | ||
| 01.10. | ABL Texcell Diagnostics Raises Its 2026 Revenue Guidance to €13.5 Million - €14.0 Million | 731 | Business Wire | Revised guidance includes the expected contribution from TEXCELL activities since their acquisition in the second half of 2026 Revised 2026 revenue guidance of €13.5 million to €14.0 million... ► Artikel lesen | |
| 30.09. | ABL Diagnostics: ABL Texcell Diagnostics: Availability of the 2026 Half-Year Financial Report | - | Euronext | ||
| 30.09. | ABL Texcell Diagnostics SA: ABL Texcell Diagnostics: Availability of the 2026 Half-Year Financial Report | 468 | Business Wire | Regulatory News:
ABL Texcell Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) (the "Company"), a company specializing in molecular diagnostic solutions, healthcare software and services supporting... ► Artikel lesen | |
| 21.09. | ABL Texcell Diagnostics SA: ABL Texcell Diagnostics Reaches a New Strategic Milestone With a Proposed Acquisition of Vela Diagnostics' Activities in Singapore and the United States | 953 | Business Wire | The Company signs a non-binding letter of intent to acquire 100% of Vela Operations Singapore and Vela Diagnostics USA, with the ambition to consolidate an integrated international platform covering... ► Artikel lesen | |
| 17.09. | ABL Diagnostics Becomes ABL Texcell Diagnostics | 666 | Business Wire | Shareholders confirm the continuation of the Company's listing on the regulated market of Euronext Paris as the most appropriate framework to support the Company's next phase of long-term development
Regulatory... ► Artikel lesen | |
| 17.09. | ABL Diagnostics Announces Its Participation in Investor Access @ Maison De La Chimie Paris 2026 | 356 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris Compartment B ISIN: FR001400AHX6 ABLD), an international company specializing in molecular diagnostic solutions, healthcare software and life sciences... ► Artikel lesen | |
| 15.09. | ABL Diagnostics to Participate in the European Main MidCap Event Paris 2026 on September 30 and October 1, 2026 | 488 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris Compartment B ISIN: FR001400AHX6 ABLD), an international company specializing in molecular diagnostic solutions, healthcare software and life sciences... ► Artikel lesen | |
| 14.09. | ABL Diagnostics SA: ABL Diagnostics Announces Availability of the Latest All Invest Securities Research Report | 652 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) (the "Company"), a company specializing in molecular diagnostic solutions, healthcare software and clinical research services... ► Artikel lesen | |
| 11.09. | ABL Diagnostics (ABLD) Announces the Filing of a Takeover Bid for Integragen | 691 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) (the "Company"), a company specialized in molecular diagnostics solutions, healthcare software and services supporting... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,860 | +0,05 % | Aktie zieht an!: Siemens liefert und legt nach, die Strategie überzeugt wirft Fragen auf | © Foto: Joko - JokoSiemens meldet Rekordzahlen und hebt die Mittelfristziele an. Anleger bleiben trotzdem skeptisch, denn die neue Konzernstrategie gilt vielen noch als zu unscharf Enthaltene Werte:... ► Artikel lesen | |
| THERMO FISHER | 634,40 | +0,48 % | 65% der untersuchten FDA-Rückschläge betrafen Produktionsstätten: Die unsichtbare Hürde für Lonza, Thermo Fisher und NeuroThera | ||
| STRATEC | 28,350 | +3,66 % | EQS-News: STRATEC SE: STRATEC berichtet finale Zahlen für die ersten neun Monate 2026 | EQS-News: STRATEC SE
/ Schlagwort(e): Quartalsergebnis
STRATEC BERICHTET FINALE ZAHLEN FÜR DIE ERSTEN NEUN MONATE 2026
12.11.2026 / 06:55 CET/CEST
Für... ► Artikel lesen | |
| UNIDOC HEALTH | 0,028 | -7,28 % | CSE Bulletin: Reinstatement - UniDoc Health Corp. (UDOC) | Le 7 octobre/October 2026
Effective immediately, UniDoc Health Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
__________________________
En... ► Artikel lesen | |
| DIASORIN | 79,80 | -1,92 % | DiaSorin 9-Month Net Profit Up, Despite Lower EBITDA | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Thursday reported nine-month 2026 net profit of EUR 126 million, down 8 percent from EUR 137.1 million a year earlier. Revenue edged up 1 percent... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,860 | -1,82 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius schließt Verkauf von 13,4 Millionen Aktien der Fresenius Medical Care zu 39,00 Euro je Aktie ab und erzielt rund 524 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius schließt Verkauf von 13,4 Millionen Aktien der Fresenius Medical Care zu 39,00... ► Artikel lesen | |
| FRESENIUS | 52,38 | -1,97 % | EQS-News: Fresenius SE & Co. KGaA: Moody's hebt Kreditausblick für Fresenius von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
Moody's hebt Kreditausblick für Fresenius von stabil auf positiv an (News mit Zusatzmaterial)
19.11.2026 / 13:45... ► Artikel lesen | |
| BILLIONTOONE | 90,51 | -7,17 % | BillionToOne weist Vorwürfe aus Leerverkäufer-Bericht zurück | ||
| CARL ZEISS MEDITEC | 32,580 | +0,99 % | Carl Zeiss Meditec-Aktie -3%: Jetzt die Reißleine ziehen? | Die Aktie von Carl Zeiss Meditec gab am Mittwoch zeitweise mehr als 3% nach, FMC verlor im Dax bis zu 2%. Beide Titel konnten sich damit der Stabilisierung am Gesamtmarkt nicht anschließen, Auslöser... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 65,82 | -3,69 % | BMO raises BrightSpring Health stock price target on LDD momentum | ||
| UNITEDHEALTH | 303,00 | -4,96 % | UnitedHealth-Aktie -15%: Washington zieht die Daumenschrauben an - trotzdem kaufen? | Es ist bislang eine rabenschwarze Woche für die UnitedHealth-Aktie. Am Dienstag und am Mittwoch brach der Kurs der größten privaten US-Krankenversicherung in Summe um -15% ein. Was steckt hinter dem... ► Artikel lesen | |
| DRAEGERWERK | 116,80 | -1,85 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| HEARTFLOW | 45,770 | -0,26 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| OTTOBOCK | 38,150 | +1,06 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): 9-Monatszahlen
Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort
12.11.2026 / 07:30 CET/CEST
Für den... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,455 | -2,29 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |